Oncology: Musculoskeletal Tumor Program
Comprehensive care for bone and soft tissue tumors
The Musculoskeletal Tumor Program at Children’s Medical Center, part of the nationally recognized Pauline Allen Gill Center for Cancer and Blood Disorders, offers comprehensive, multidisciplinary treatment of benign and malignant bone and soft tissue tumors including Ewing sarcoma, osteosarcoma and soft tissue sarcomas.
What We Treat
We strive to deliver best-in-class, evidence-based care to children with benign and malignant musculoskeletal tumors including:
- Benign bone and soft tissue tumors including but not limited to:
- Aneurysmal and unicameral bone cysts
- Non-ossifying fibroma
- Malignant musculoskeletal tumors including but not limited to:
- Ewing’s sarcoma
- Rhabdomyosarcoma and non-rhabdomyosarcoma soft tissue sarcoma
Patients will be evaluated by an orthopedic oncology surgeon or the sarcoma team. Patients with complex disease and/or malignant disease will be treated in the Gill Center at Children’s.
The treatment team consists of pediatric oncologists, orthopedic oncology surgeons, radiologists, pathologists, a nurse practitioner, nurses, psychologists, physical and occupational therapists, and prosthetists from both UT Southwestern and Texas Scottish Rite Hospital for Children.
This team of specialists and subspecialists within the Musculoskeletal Tumor Program at Children’s meets weekly to develop treatment plans for newly diagnosed patients, patients in relapse and patients whose care is at complex decision-making junctures.